Trials / Completed
CompletedNCT00327834
Atomoxetine in the Treatment of Binge Eating Disorder
Atomoxetine in the Treatment of Binge Eating Disorder: A Single-Center, Double-Blind, Placebo-Controlled, Flexible Dose Study in Outpatients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Lindner Center of HOPE · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The specific aim of this study is to assess the efficacy and safety of atomoxetine compared with placebo in outpatients with binge eating disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | atomoxetine |
Timeline
- Start date
- 2006-05-01
- Primary completion
- 2007-03-01
- Completion
- 2007-03-01
- First posted
- 2006-05-19
- Last updated
- 2011-06-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00327834. Inclusion in this directory is not an endorsement.